Guideline decision tool · Oncology
🎗️

Ovarian Cancer Suidan Score (Suboptimal Cytoreduction Prediction) — free guideline decision tool

Predict suboptimal primary cytoreduction (residual > 1 cm) risk in advanced ovarian cancer from pre-operative CT findings, CA-125 and clinical factors. Instant, browser-side.

Open guideline tool →
Computed locally — no data uploaded. For licensed clinicians.
📋

Guideline-based

Implements the decision logic from published clinical guidelines.

🖥️

Runs in your browser

No installation. Enter the patient's values and get a guideline recommendation instantly.

🔒

Data stays local

Nothing is uploaded. Results are for licensed clinicians only.

Common questions

What does Ovarian Cancer Suidan Score (Suboptimal Cytoreduction Prediction) do?

Support the primary-debulking vs neoadjuvant-chemotherapy decision in advanced ovarian/tubal/peritoneal cancer.

How is the result calculated?

Weighted sum: lesser sac +4; ASA 3–4 +3; perisplenic / small-bowel mesentery / SMA root each +2; age ≥ 60 / CA-125 ≥ 500 / suprarenal nodes / diffuse small bowel each +1. Bands 0 → ~ 5%, up to ≥ 9 → ~ 74% suboptimal.

Is this a substitute for clinical judgement?

No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.

🎗️

Run Ovarian Cancer Suidan Score (Suboptimal Cytoreduction Prediction) now

Predict suboptimal primary cytoreduction (residual > 1 cm) risk in advanced ovarian cancer from pre-operative CT findings, CA-125 and clinical factors. Instant, browser-side.

Open guideline tool →

For licensed clinicians. Not a substitute for clinical judgement.

Share on XLinkedInFacebook

Related guideline tools

For use by licensed clinicians and clinical researchers. Computed locally in your browser — no data is uploaded. Not a substitute for clinical judgement.